Application

SYNDURVA

Heron Therapeutics, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 05/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90780093
Filing Date: 06/17/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90780093
MARK INFORMATION
*MARK SYNDURVA
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT SYNDURVA
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Heron Therapeutics, Inc.
*MAILING ADDRESS 4242 Campus Point Court, Suite 200
*CITY San Diego
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92121
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations and substances, namely, anesthetics for surgical purposes; anesthetics for surgical use; local anesthetics; topical anesthetics; general anesthetics; anti-inflammatory preparations; anti-inflammatory ointments; analgesic preparations; preparations for the relief of pain; anesthetics for peri-operative and post-operative use; pharmaceutical preparations and substances for use in anesthesia and for the treatment and control of pain
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Beth M. Goldman
ATTORNEY DOCKET NUMBER 21539-6000
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Orrick, Herrington & Sutcliffe LLP
INTERNAL ADDRESS IP Prosecution Department
STREET 2050 Main Street, Suite 1100
CITY Irvine
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 92614-8255
PHONE 415-773-5700
FAX 949-567-6710
EMAIL ADDRESS ipprosecutionsf@orrick.com
OTHER APPOINTED ATTORNEY Betsy Wang Lee, Eileen Z. Aghnami, Bela K. Karmel, Kristin S. Cornuelle, Diana M. Rutowski, Peter D. Vogl, Briggs M. Wright, Robert M. O'Connell Jr.
CORRESPONDENCE INFORMATION
NAME Beth M. Goldman
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ipprosecutionsf@orrick.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) beth.goldman@orrick.com; blee@orrick.com; eaghnami@orrick.com; aparker@orrick.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /Thomas Ottoboni/
SIGNATORY'S NAME Thomas Ottoboni
SIGNATORY'S POSITION Senior VP
SIGNATORY'S PHONE NUMBER 415-773-5700
DATE SIGNED 06/17/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 05/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 90780093
Filing Date: 06/17/2021

To the Commissioner for Trademarks:

MARK: SYNDURVA (Standard Characters, see mark)
The literal element of the mark consists of SYNDURVA. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Heron Therapeutics, Inc., a corporation of Delaware, having an address of
      4242 Campus Point Court, Suite 200
      San Diego, California 92121
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations and substances, namely, anesthetics for surgical purposes; anesthetics for surgical use; local anesthetics; topical anesthetics; general anesthetics; anti-inflammatory preparations; anti-inflammatory ointments; analgesic preparations; preparations for the relief of pain; anesthetics for peri-operative and post-operative use; pharmaceutical preparations and substances for use in anesthesia and for the treatment and control of pain
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Beth M. Goldman. Other appointed attorneys are Betsy Wang Lee, Eileen Z. Aghnami, Bela K. Karmel, Kristin S. Cornuelle, Diana M. Rutowski, Peter D. Vogl, Briggs M. Wright, Robert M. O'Connell Jr.. Beth M. Goldman of Orrick, Herrington & Sutcliffe LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      IP Prosecution Department
      2050 Main Street, Suite 1100
      Irvine, California 92614-8255
      United States
      415-773-5700(phone)
      949-567-6710(fax)
      ipprosecutionsf@orrick.com
The docket/reference number is 21539-6000.
Beth M. Goldman submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Beth M. Goldman
       PRIMARY EMAIL FOR CORRESPONDENCE: ipprosecutionsf@orrick.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): beth.goldman@orrick.com; blee@orrick.com; eaghnami@orrick.com; aparker@orrick.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Thomas Ottoboni/   Date: 06/17/2021
Signatory's Name: Thomas Ottoboni
Signatory's Position: Senior VP
Signatory's Phone Number: 415-773-5700
Signature method: Sent to third party for signature
Payment Sale Number: 90780093
Payment Accounting Date: 06/17/2021

Serial Number: 90780093
Internet Transmission Date: Thu Jun 17 15:29:29 ET 2021
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XX-20210617152929237
870-90780093-780e137b2981555b75943412ded
6a763a5ec9b69b685ab161dd52ebb25ef93cb-DA
-29284252-20210609115844488210

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed